What is schizophrenia: A neurodevelopmental or neurodegenerative disorder or a combination of both A critical analysis

Indian Journal of Psychiatry

Volumn 52, Issue 1, 2010, Pages 21-27

  Gupta, Swapnil ^a   Kulhara, Parmanand ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Neurodegeneration; Neurodevelopmental; Schizophrenia

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CATALASE; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; DOPAMINE; DYSBINDIN; EPIDERMAL GROWTH FACTOR; FOLLISTATIN; GENE PRODUCT; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMIC ACID; GLUTATHIONE; N METHYL DEXTRO ASPARTIC ACID; NERVE CELL ADHESION MOLECULE; NEU DIFFERENTIATION FACTOR; NOGGIN; SOMATOMEDIN C; SUPEROXIDE DISMUTASE;

AGING; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; CELL MIGRATION; CLINICAL OBSERVATION; DEGENERATIVE DISEASE; DEVELOPMENTAL DISORDER; DOPAMINERGIC SYSTEM; EXCITOTOXICITY; FACE DYSMORPHIA; GENETIC SUSCEPTIBILITY; HUMAN; MYELINATION; NERVE CELL PLASTICITY; NEUROCHEMISTRY; NEUROIMAGING; NEUROPATHOLOGY; OXIDATIVE STRESS; PREGNANCY COMPLICATION; PSYCHODYNAMICS; REVIEW; SCHIZOPHRENIA;

EID: 77953438933     PISSN: 00195545     EISSN: 19983794     Source Type: Journal    
DOI: 10.4103/0019-5545.58891     Document Type: Review

References (60)

1. Bender L. Childhood schizophrenia: Clinical study of 100 schizophrenia children. Am J Orthopsychiatry 1947;17:40-56.
2. Watt NF. Patterns of childhood social development in adult schizophrenics. Arch Gen Psychiatry 1978;35:106-115
3. Clouston, T. Cited by Murray MR, Bramon E. In Developmental model of schizophrenia. In: Sadock BJ, Sadock VA, editors. Comprehensive Textbook of Psychiatry. 8th ed. Philadelphia: Lippincot Williams and Wilkins; 2005. p. 1381.
4. Southard EF. On the topographical distribution of cortical lesions and anomalies in dementia praecox, with some account of their functional significance. American J Insanity 1915;71:603-671
5. Jones PB, Rantakallio P, Hartikainen AL, Isohanni M, Sipila P. Schizophrenia as a long term outcome of pregnancy, delivery, and perinatal complications: A 28 year follow up of the North Finland general population birth cohort. Am J Psychiatry 1998;155:355-364
6. Wahlbeck K, Forsen T, Osmond C, Barker DJ, Eriksson JG. Association of schizophrenia with maternal body mass index, small size at birth and thinness during childhood. Arch Gen Psychiatry 2001;58:48-52. (Pubitemid 32057764)
7. Sørensen HJ, Mortensen EL, Reinisch JM, Mednick SA. Do hypertension and diuretic treatment in pregnancy increase the risk of schizophrenia in offspring? Am J Psychiatry 2003;160:464-468
8. Cannon M, Jones BP, Murray RM. Obstetric complications and schizophrenia: Historical and meta-analytic review. Am J Psychiatry 2002;159:1080-1092
9. Zornberg G, Buka SL, Tsuang MT. The problem of obstetrical complications and schizophrenia. Schizophr Bull 2000;26:249-256
10. Geddes JR, Verdoux H, Taikei N, Lawrie SM, Bovet P, Eagles JM, et al. Schizophrenia and complications of pregnancy and labour: An individual patient data meta-analysis. Schizophr Bull 1999;25:413-423
11. Mednick SA, Machon RA, Huttunen MO, Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988;45:189-192
12. Kendell RE, Kemp IW. Maternal influenza in the aetiology of schizophrenia. Arch Gen Psychiatry 1989;46:878-882
13. Kunugi H, Nanko S, Takei N, Saito K, Hayashi N, Kazamatsuri H. Schizophrenia following in utero exposure to the 1957 influenza epidemics in Japan. Am J Psychiatry 1995;152:450-452
14. Crow TJ, Done DJ. Prenatal exposure to influenza does not cause schizophrenia. Br J Psychiatry 1992;161:390-393
15. Selten JP, Slaets JP. Evidence against maternal influenza as a risk factor for schizophrenia. Br J Psychiatry 1994;164:674-676
16. Susser E, Lin SP, Brown AS, Lumey LH, Erlenmeyer-Kimling L. No relation between risk of schizophrenia and prenatal exposure to influenza in Holland. Am J Psychiatry 1994;151:922-924
17. Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D, et al. Schizophrenia after prenatal famine: further evidence. Arch Gen Psychiatry 1996;53:25-31.
18. Greene MF, Satz P, Gaier DJ, Ganzell S, Kharabi F. Minor physical anomalies in schizophrenia. Schizophr Bull 1989;15:91-99
19. Lane A, Kinsella A, Murphy P, Byrne M, Keenan J, Colgan K, et al. The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins. Psychol Med 1997;27:1155-1164
20. Lane A, Larkin C, Waddington JI, O'Callaghan, E. Dysmorphic features in schizophrenia. In: Waddington JI, Buckley PF, editors. The neurodevelopmental basis of schizophrenia. Georgetown, TX: R.G. Landes; 1996. p. 79-94.
21. Fearon P, Lane A, Airie M, Scannell J, McGowan A, Byrne M, et al. Is reduced dermatoglyphic a-b ridge count a reliable marker of developmental impairment in schizophrenia? Schizophr Res 2001;50:151-157
22. Murray MR, Bramon E. Developmental model of schizophrenia. In: Sadock BJ, Sadock VA, editors. Comprehensive Textbook of Psychiatry. 8th ed. Philadelphia: Lippincot Williams and Wilkins; 2005. p. 1385.
23. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res 2001;49:1-52.
24. Nopoulos PC, Giedd JN, Andreasen NC, Rapoport JL. Frequency and Severity of Enlarged Cavum Septi Pellucidi in Childhood-Onset Schizophrenia. Am J Psychiatry 1998;155:1074-1079
25. Jacobsen LK, Giedd JN, Vaituzis AC, Hamburger MD, Rajapakse JC, Frazier JA, et al. Temporal Lobe Morphology in Childhood-Onset Schizophrenia. Am J Psychiatry 1996;153:355-361
26. Akbarian S, Bunney WE, Potkin SG, Wigal SB, Hagman JO, Sandman CA, et al. Altered distribution of nicotamine-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 1993;50:169-177 (Pubitemid 23077471)
27. Anderson SA, Volk DW, Lewis DA. Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr Res 1996;19:111-119
28. Jacob H, Beckmann H. Prenatal developmental disturbances in the limbic allocortex of schizophrenics. J Neural Transm 1986;65:303-326
29. Heinsen H, Gossman G, Rub U, Eisenmenger W, Bauer M, Ulmar G, et al. Variability in the human entorhinal region may confound neuropsychiatric diagnosis. Acta Anat (Basel) 2000;157:226-237
30. Akil M, Lewis DA. Cytoarchitechture of the entorhinal cortex in schizophrenia. 1997. Am J Psychiatry 1997;154:1010-1012
31. Krimer LS, Hyde TM, Herman MM, Saunders RC. The entorhinal cortex: an examination of cyto and myeloarchitectonic organization in humans. Cereb Cortex 1997;7:722-731
32. Bernstein HG, Krell D, Baumann B, Danos P, Falkai P, Diekmann S, et al. Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia. Schizophr Res 1998;35:125-132
33. Ishizuka K, Paek M, Kamiya A, Sawa A. A review of disrupted in schizophrenia-1 (disc1): Neurodevelopment, cognition and mental conditions. Biol Psychiatry 2006;59:1189-1197
34. Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 1998;95:15718-15723
35. Vawter MP, Usen N, Thatcher L, Ladenheim B, Zhang P, VanderPutten DM, et al. Characterization of human cleaved N-CAM and association with schizophrenia. Exp Neurol 2001;172:29-46.
36. Barbeau D, Liang JJ, Robitaille Y, Quirion Y, Srivastava IK. Decreased expression of the embryonic form of the neural cell-adhesion molecule in schizophrenic brains. Proc Natl Acad Sci U.S.A 1995;92:2785-2789
37. Feinberg I. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1983;17:319-334
38. Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. Arch Gen Psychiatry 1991;48:563-568
39. Jernigan TL, Tallal P. Late childhood changes in brain morphology observable with MRI. Dev Med and Child Neurol 1990;32:379-385
40. Chugani HT, Phelps ME, Mazziotta JC. Positron-emission tomography study of human brain functional development. Annals Neurol 1997;22:487-497
41. Keshavan MS, Reynolds CF 3rd, Miewald JM, Montrose DM, Sweeney JA, Vasko RC Jr, et al. Delta sleep deficits in schizophrenia: evidence from automated analyses of sleep data. Arch Gen Psychiatry 1998;55:443-448
42. Zipursky RB, Lim KO, Sullivan EV, Brown BW, Pfefferbaum A. Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry 1992;49:195-205.
43. Andreasen N, Rezai K, Alliger R, Swayze VW 2nd, Flaum M, Kirchner P, et al. Hypofrontality in neuroleptic-naive patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992;49:943-958
44. McGlashan TH, Hoffman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000;57:637-648
45. Selemon J, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex. Arch Gen Psychiatry 1995;52:805-818
46. Hardy H, Gwinn-Hardy K. Genetic classification of primary neurodegenerative disease. Science 1998;282:1075-1079
47. Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull 1991;17:325-351
48. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. Am J Psychiatry 2005;162:1785-1804
49. Keshavan MS. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res 1999;33:513-521
50. Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001;58:24-32.
51. Hoff AL, Svetina C, Shields G, Stewart J, DeLisi LE. Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr Res 2005;78:27-34.
52. Gold S, Arndt S, Nopoulos P, O'Leary DS, Andreasen NC. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am J Psychiatry 1999;156:1342-1348
53. Harrison PJ. The neuropathology of schizophrenia: A critical review of the data and their interpretation. Brain 1999;122:593-624.
54. Lieberman JA, Sheitman BB, Kinon BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997;17:205-229
55. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995;52:998-1007.
56. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 1991;48:996-1001.
57. Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L. Oxidative stress involvement in schizophrenia pathophysiology: a review. Encephale 2006;32:244-252
58. Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry 1998;155:1661-1670
59. Takahata R, Moghaddam B. Gluatmatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex. J Neurochem 1998;71:1443-1449
60. Grace AA. Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J Neural Transm Gen Sect 1993;91:111-134